Cell Savers and Blood Quality
Sponsored by University Medical Center Groningen
About this trial
Last updated 9 years ago
Study ID
Cell Saver-001
Status
Terminated
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 10 years ago
What is this trial about?
Cell savers are routinely used in our hospital during off-pump coronary artery bypass
grafting to retrieve and wash blood that is lost during the operation. This washed blood is
retransfused to the patient in order to prevent allogeneic blood transfusion. However, little
is known about the rheologic properties and oxygen transport capacity of the washed red blood
cells and the effects of retransfusion of this blood on microcirculatory blood flow and organ
damage in the patient. For cell savers 3 different operating principles exist. The most
common one uses discontinuous blood washing with a spinning bowl that is intermittently
filled with blood, processed and emptied. A second one uses a continuous blood washing
principle with a rotational disk. A third one is intermediate using features of both the
discontinuous bowl technology and the continuous rotational disc technology.
The investigator hypothesize that the operating principle has effects on the rheologic
properties and oxygen transport capacity of the washed blood.
Previous research suggested that in particular the deformability and oxygen carrier
properties of the red blood cells are affected. As a consequence, red blood cells may block
small blood vessels, which affects microcirculatory blood flow and tissue oxygenation. This
may lead to organ damage.
What are the participation requirements?
Inclusion Criteria
- Scheduled for OPCABG surgery
- Age > 18 years
- Informed consent
Exclusion Criteria
- A potential subject who meets any of the following criteria will be excluded from participation in this study: Patients with known hematologic or microvascular disorders. Patients will be excluded intraoperatively when conversion to on-pump coronary artery bypass grafting is necessary or when allogeneic red blood cell transfusion is required.